Sexual Health
Conference Coverage
When it comes to young women, regular check-ins support ongoing PrEP use
This is important in the U.S. because cisgender Black women make up 60% of all new HIV cases in the U.S. while accounting for just 14% of the U.S...
News
CDC revamps STI treatment guidelines
Conference Coverage
Success in LGBTQ+ medicine requires awareness of risk
Cross-sex hormone therapy is a life-sustaining treatment that should be viewed analogously with any other long-term management strategy, such as...
Latest News
HPV vaccination rates continue to climb among young adults in U.S.
For persons who have not previously received the HPV vaccine or who did not receive adequate doses, the HPV vaccine is recommended through age 26...
From the Journals
Pityriasis rosea carries few risks for pregnant women
The latest retrospective study showed a 24% overall complication rate for pregnant women with PR, but most complications were mild.
Gynecologic Oncology Consult
Treating VIN while preventing recurrence
VIN is particularly problematic because more than a quarter of patients will experience recurrence of their disease after primary therapy.
From the Journals
Nearly half of STI events go without HIV testing
Missed opportunities for HIV diagnosis have the potential to delay linkage to antiretroviral therapy or PrEP and prevention services.
From the Journals
Requests for crowd diagnoses of STDs common on social media
From the Journals
USPSTF: Screening pregnant women for asymptomatic bacteriuria cuts pyelonephritis risk
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
News from the FDA/CDC
ACIP extends HPV vaccine coverage
Committee voted for catch-up vaccination for all individuals through age 26 years, optional for older adults.
News
FDA grants marketing clearance for chlamydia and gonorrhea extragenital tests
The new tests use samples from the throat and rectum.